| Nov 23 2020 |
Pennsylvania Court Affirms Unemployment Benefits for Medical Marijuana User |
Jackson Lewis P.C. |
| Nov 23 2020 |
Transatlantic Trade: US and Europe – Week of November 16, 2020 |
Squire Patton Boggs (US) LLP |
| Nov 23 2020 |
FDA Issues Final Guidance for Industry and FDA Staff on Publicizing Lists of Retailers That May Have Received Certain Recalled Food |
Keller and Heckman LLP |
| Nov 23 2020 |
A Record-Breaking Year in Digital Health Investments: Key Takeaways | HTLH GoLive Webinar |
Foley & Lardner LLP |
| Nov 21 2020 |
New York Announces CBD Product Guidelines |
Hinch Newman LLP |
| Nov 20 2020 |
COVID-19 Weekly Newsletter: Vaccine Update, Thanksgiving Guidance |
Faegre Drinker |
| Nov 20 2020 |
H.R. 4712: A “Narrowly Tailored” Obligation Under the Orphan Drug Act? |
Proskauer Rose LLP |
| Nov 20 2020 |
FDA Releases New Outbreak Investigation Table |
Keller and Heckman LLP |
| Nov 20 2020 |
Florida Department of Health Issues 5 Notices of Emergency Rules Related to Medical Marijuana Treatment Centers |
Greenberg Traurig, LLP |
| Nov 19 2020 |
New York State Drafts Rules for CBD in Foods and Dietary Supplements |
Keller and Heckman LLP |
| Nov 19 2020 |
FDA Adds Thirteen New Substances to its Inventory of Effective FCS Notifications |
Keller and Heckman LLP |
| Nov 18 2020 |
Tripping on Hallucinogenics in Oregon: Two New Measures Decriminalize Certain Narcotics and Legalize Psilocybin Therapy |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Nov 18 2020 |
New Jersey Restrictions Return for Bars and Restaurants as COVID-19 Cases Increase |
Norris McLaughlin P.A. |
| Nov 18 2020 |
Addressing COVID-19 Vaccine Supply Chain Challenges |
Squire Patton Boggs (US) LLP |
| Nov 18 2020 |
California Federal Court Hears Motion to Dismiss Class Action on “Manufactured in USA” Claims by Bigelow Tea |
Keller and Heckman LLP |
| Nov 18 2020 |
Green Wave: The Latest Election Cycle Brings Hope for Standardized Cannabis Legalization |
Sheppard, Mullin, Richter & Hampton LLP |
| Nov 17 2020 |
Special Fraud Alert: OIG Raises Concerns With Speaker Programs |
McDermott Will & Schulte LLP |
| Nov 17 2020 |
Class Action Lawsuits Challenge “Grain Free” Claim on Dog Food Products |
Keller and Heckman LLP |
| Nov 16 2020 |
HHS OIG Issues Special Fraud Alert Targeting Pharmaceutical and Medical Device Speaker Programs |
Dinsmore & Shohl LLP |
| Nov 16 2020 |
Minimum Wage and Marijuana on the Ballot |
Foley & Lardner LLP |
| Nov 16 2020 |
Texas Court Treats 124 Separate Food Poisoning Cases as Single “Occurrence” |
Hunton Andrews Kurth |
| Nov 16 2020 |
Arizona Beverages Alleges Federal Preemption of State Fraud Claims in a Class Action Lawsuit Alleging Misrepresentation of Calories Per Serving on Arnold Palmer Drinks Labeled as Zero-Calorie |
Keller and Heckman LLP |
| Nov 13 2020 |
Pharmacy Compliance: What Do You Need to Know? |
Oberheiden P.C. |
| Nov 13 2020 |
Preemption of Structure/Function Claims |
Faegre Drinker |
| Nov 12 2020 |
Explanatory Statement for EPA Appropriations Bill Directs EPA Administrator to Involve FDA in NanoEHS Research |
Bergeson & Campbell, P.C. |
| Nov 12 2020 |
EPA Proposes Revised Crop Groups for Herbs and Spices |
Bergeson & Campbell, P.C. |
| Nov 12 2020 |
Divided FTC Finalizes “No-Fault, No-Money Settlement” Agreement with Skincare Brand, Sunday Riley |
Hunton Andrews Kurth |
| Nov 12 2020 |
COVID-19: FDA Warning Letters Address Fraudulent Products and Failures to Meet EUA Requirements [PODCAST] |
K&L Gates LLP |
| Nov 12 2020 |
Brexit: Phased Approach for Northern Ireland Protocol (NIP) for the Pharmaceuticals Sector |
Squire Patton Boggs (US) LLP |
| Nov 11 2020 |
“Fruit Puree” Held a Fair Game First Ingredient in Fruit Snacks Label by California Court of Appeal |
Faegre Drinker |
| Nov 11 2020 |
Marijuana Ballot Initiatives Approved in Five States: What This Budding Trend Means for Employers |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Nov 11 2020 |
Rage Against the Vaccine: Communicating COVID-19 Facts Amid Anti-Vaxxer Outcry |
Hennes Communications |
| Nov 11 2020 |
Venue in Hatch-Waxman Cases Limited to District Where ANDA Is Submitted |
McDermott Will & Schulte LLP |
| Nov 11 2020 |
FDA Publishes Draft Guidance for the Voluntary Disclosure of Sesame |
Keller and Heckman LLP |
| Nov 10 2020 |
Arizona and Three More States Approve Recreational Marijuana Use: Hashing Out What This Means for Employers (US) |
Squire Patton Boggs (US) LLP |
